Literature DB >> 23818138

Hysterectomy and kidney cancer risk: a meta-analysis.

Sara Karami1, Sarah E Daugherty, Mark P Purdue.   

Abstract

Recent cohort findings suggest that women who underwent a hysterectomy have an elevated relative risk of kidney cancer, although evidence from past studies has been inconsistent. We conducted a systematic review and meta-analysis of published cohort and case-control studies to summarize the epidemiologic evidence investigating hysterectomy and kidney cancer. Studies published from 1950 through 2012 were identified through a search of PubMed and of references from relevant publications. Meta-analyses were conducted using random-effects models to estimate summary relative risks (SRRs) and 95% confidence intervals (CIs) for hysterectomy, age at hysterectomy (<45, 45+ years) and time since hysterectomy (<10, 10+ years). The SRR for hysterectomy and kidney cancer for all published studies (seven cohort, six case-control) was 1.29 (95% CI, 1.16-1.43), with no evidence of between-study heterogeneity or publication bias. The summary effect was slightly weaker, although still significant, for cohorts (SRR, 1.26; 95% CI, 1.11-1.42) compared with case-control findings (1.37; 95% CI, 1.09-1.73) and was observed irrespective of age at hysterectomy, time since the procedure and model adjustment for body mass index, smoking status and hypertension. Women undergoing a hysterectomy have an approximate 30% increased relative risk of subsequent kidney cancer. Additional research is needed to elucidate the biological mechanisms underlying this association. Published 2013. This article is a US Government work and, as such, is in the public domain of the United States of America.

Entities:  

Keywords:  hysterectomy; kidney cancer; meta-analysis

Mesh:

Year:  2013        PMID: 23818138      PMCID: PMC3834077          DOI: 10.1002/ijc.28352

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  44 in total

1.  Central hemodynamic assessment of normal term pregnancy.

Authors:  S L Clark; D B Cotton; W Lee; C Bishop; T Hill; J Southwick; J Pivarnik; T Spillman; G R DeVore; J Phelan
Journal:  Am J Obstet Gynecol       Date:  1989-12       Impact factor: 8.661

Review 2.  Epidemiology of adenocarcinoma of the kidney.

Authors:  E L Wynder; K Mabuchi; W F Whitmore
Journal:  J Natl Cancer Inst       Date:  1974-12       Impact factor: 13.506

3.  Accuracy of recall of surgical histories: a comparison of postal survey data and general practice records.

Authors:  A Coulter; K McPherson; S Elliott; B Whiting
Journal:  Community Med       Date:  1985-08

4.  Risk factors for kidney cancer in New South Wales, Australia. II. Urologic disease, hypertension, obesity, and hormonal factors.

Authors:  M McCredie; J H Stewart
Journal:  Cancer Causes Control       Date:  1992-07       Impact factor: 2.506

5.  Obstruction of the upper urinary tract after treatment of carcinoma of the uterine cervix.

Authors:  U Ulmsten
Journal:  Acta Obstet Gynecol Scand       Date:  1975       Impact factor: 3.636

6.  Second cancer following cancer of the female genital system in Denmark, 1943-80.

Authors:  H H Storm; M Ewertz
Journal:  Natl Cancer Inst Monogr       Date:  1985-12

7.  Second cancer following cancer of the female genital system in Connecticut, 1935-82.

Authors:  R E Curtis; R N Hoover; R A Kleinerman; E B Harvey
Journal:  Natl Cancer Inst Monogr       Date:  1985-12

8.  Reproducibility and validity of self-reported menopausal status in a prospective cohort study.

Authors:  G A Colditz; M J Stampfer; W C Willett; W B Stason; B Rosner; C H Hennekens; F E Speizer
Journal:  Am J Epidemiol       Date:  1987-08       Impact factor: 4.897

9.  The natural history of hydronephrosis after radical hysterectomy with no intraoperatively recognisable injury to the ureter: a prospective study.

Authors:  S H Paick; S J Oh; Y S Song; H H Kim
Journal:  BJU Int       Date:  2003-11       Impact factor: 5.588

10.  Second malignancies following testicular cancer, ovarian cancer and Hodgkin's disease: an international collaborative study among cancer registries.

Authors:  J M Kaldor; N E Day; P Band; N W Choi; E A Clarke; M P Coleman; M Hakama; M Koch; F Langmark; F E Neal
Journal:  Int J Cancer       Date:  1987-05-15       Impact factor: 7.396

View more
  6 in total

1.  Second primary malignancies in renal cortical neoplasms: an updated evaluation from a single institution.

Authors:  Katie S Murray; Emily C Zabor; Massimiliano Spaliviero; Paul Russo; Wassim M Bazzi; John E Musser; A Ari Hakimi; Melanie L Bernstein; Guido Dalbagni; Jonathan A Coleman; Helena Furberg
Journal:  World J Urol       Date:  2016-04-22       Impact factor: 4.226

2.  A systematic assessment of the association between frequently prescribed medicines and the risk of common cancers: a series of nested case-control studies.

Authors:  R D McDowell; C Hughes; P Murchie; C Cardwell
Journal:  BMC Med       Date:  2021-01-26       Impact factor: 8.775

Review 3.  Long-term intermittent pharmacological therapy of uterine fibroids - a possibility to avoid hysterectomy and its negative consequences.

Authors:  Anita Olejek; Katarzyna Olszak-Wąsik; Anna Czerwinska-Bednarska
Journal:  Prz Menopauzalny       Date:  2016-03-29

Review 4.  Gender-Related Approach to Kidney Cancer Management: Moving Forward.

Authors:  Mariangela Mancini; Marialaura Righetto; Giovannella Baggio
Journal:  Int J Mol Sci       Date:  2020-05-10       Impact factor: 5.923

5.  Therapeutic role of uterine-derived stem cells in acute kidney injury.

Authors:  Ramanaiah Mamillapalli; SiHyun Cho; Levent Mutlu; Hugh S Taylor
Journal:  Stem Cell Res Ther       Date:  2022-03-12       Impact factor: 6.832

Review 6.  Epidemiology and Risk Factors for Kidney Cancer.

Authors:  Ghislaine Scelo; Tricia L Larose
Journal:  J Clin Oncol       Date:  2018-10-29       Impact factor: 44.544

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.